Mingming Zhang , Youtao Zhang , Fangming Cheng , Hong Chen , Yonghong Yang , Li Li , Yuzhang Jiang , Yaping Dai , Fang Qiu , Zhuye Qin , Chongxu Han , Gang Wang , Xingjuan Shi , Chungen Qian , Xiangdong Liu
{"title":"一种用于PR3-ANCA检测的嵌合单克隆抗体的研制。","authors":"Mingming Zhang , Youtao Zhang , Fangming Cheng , Hong Chen , Yonghong Yang , Li Li , Yuzhang Jiang , Yaping Dai , Fang Qiu , Zhuye Qin , Chongxu Han , Gang Wang , Xingjuan Shi , Chungen Qian , Xiangdong Liu","doi":"10.1016/j.jim.2025.113903","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The quantification of antineutrophil cytoplasmic antibodies (ANCA) against proteinase 3 (PR3) is crucial for diagnosing and monitoring granulomatosis with polyangiitis (GPA). However, a standardized and widely available quantitative reference material for PR3-ANCA detection remains lacking.</div></div><div><h3>Objective</h3><div>This study aims to develop and evaluate the properties of a novel chimeric human-mouse PR3 monoclonal antibody as a potential quantitative reference for PR3-ANCA detection using various in vitro diagnostic methods.</div></div><div><h3>Methods</h3><div>Mouse monoclonal antibodies were screened from hybridoma cells derived from mice immunized with recombinant human PR3 (rPR3). A high-affinity monoclonal antibody (A07) was sequenced, and a chimeric antibody incorporating human IgG1 constant regions was produced using a mammalian cell expression system. The antibody's binding to PR3 and its applicability in indirect immunofluorescence (IIF) assay, line-blotting, enzyme-linked immunosorbent assay (ELISA), and chemiluminescence immunoassay (CLIA) were analyzed.</div></div><div><h3>Results</h3><div>The chimeric A07 antibody recognized the conformational epitopes with high affinity for only non-denatured PR3 and demonstrated the correct cytoplasmic staining pattern in IIF. Line-blotting assays confirmed its specificity and potency. ELISA and CLIA experiments showed well-defined standard curves, with the chimeric antibody displaying consistent reactivity comparable to native PR3-ANCA in serum samples across different antigen conditions.</div></div><div><h3>Conclusions</h3><div>These findings indicate that the chimeric A07 antibody effectively recognizes both recombinant and native PR3 antigens and can be applied across multiple in vitro PR3-ANCA assays. Furthermore, this antibody may serve as a standard reference for determining serum PR3-ANCA titers or as a substitute for PR3-positive serum in diagnostic applications.</div></div>","PeriodicalId":16000,"journal":{"name":"Journal of immunological methods","volume":"542 ","pages":"Article 113903"},"PeriodicalIF":1.6000,"publicationDate":"2025-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Development of a chimeric monoclonal antibody as a potential diagnostic reference in PR3-ANCA detection\",\"authors\":\"Mingming Zhang , Youtao Zhang , Fangming Cheng , Hong Chen , Yonghong Yang , Li Li , Yuzhang Jiang , Yaping Dai , Fang Qiu , Zhuye Qin , Chongxu Han , Gang Wang , Xingjuan Shi , Chungen Qian , Xiangdong Liu\",\"doi\":\"10.1016/j.jim.2025.113903\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>The quantification of antineutrophil cytoplasmic antibodies (ANCA) against proteinase 3 (PR3) is crucial for diagnosing and monitoring granulomatosis with polyangiitis (GPA). However, a standardized and widely available quantitative reference material for PR3-ANCA detection remains lacking.</div></div><div><h3>Objective</h3><div>This study aims to develop and evaluate the properties of a novel chimeric human-mouse PR3 monoclonal antibody as a potential quantitative reference for PR3-ANCA detection using various in vitro diagnostic methods.</div></div><div><h3>Methods</h3><div>Mouse monoclonal antibodies were screened from hybridoma cells derived from mice immunized with recombinant human PR3 (rPR3). A high-affinity monoclonal antibody (A07) was sequenced, and a chimeric antibody incorporating human IgG1 constant regions was produced using a mammalian cell expression system. The antibody's binding to PR3 and its applicability in indirect immunofluorescence (IIF) assay, line-blotting, enzyme-linked immunosorbent assay (ELISA), and chemiluminescence immunoassay (CLIA) were analyzed.</div></div><div><h3>Results</h3><div>The chimeric A07 antibody recognized the conformational epitopes with high affinity for only non-denatured PR3 and demonstrated the correct cytoplasmic staining pattern in IIF. Line-blotting assays confirmed its specificity and potency. ELISA and CLIA experiments showed well-defined standard curves, with the chimeric antibody displaying consistent reactivity comparable to native PR3-ANCA in serum samples across different antigen conditions.</div></div><div><h3>Conclusions</h3><div>These findings indicate that the chimeric A07 antibody effectively recognizes both recombinant and native PR3 antigens and can be applied across multiple in vitro PR3-ANCA assays. Furthermore, this antibody may serve as a standard reference for determining serum PR3-ANCA titers or as a substitute for PR3-positive serum in diagnostic applications.</div></div>\",\"PeriodicalId\":16000,\"journal\":{\"name\":\"Journal of immunological methods\",\"volume\":\"542 \",\"pages\":\"Article 113903\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-07-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of immunological methods\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0022175925001036\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"BIOCHEMICAL RESEARCH METHODS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of immunological methods","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0022175925001036","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
Development of a chimeric monoclonal antibody as a potential diagnostic reference in PR3-ANCA detection
Background
The quantification of antineutrophil cytoplasmic antibodies (ANCA) against proteinase 3 (PR3) is crucial for diagnosing and monitoring granulomatosis with polyangiitis (GPA). However, a standardized and widely available quantitative reference material for PR3-ANCA detection remains lacking.
Objective
This study aims to develop and evaluate the properties of a novel chimeric human-mouse PR3 monoclonal antibody as a potential quantitative reference for PR3-ANCA detection using various in vitro diagnostic methods.
Methods
Mouse monoclonal antibodies were screened from hybridoma cells derived from mice immunized with recombinant human PR3 (rPR3). A high-affinity monoclonal antibody (A07) was sequenced, and a chimeric antibody incorporating human IgG1 constant regions was produced using a mammalian cell expression system. The antibody's binding to PR3 and its applicability in indirect immunofluorescence (IIF) assay, line-blotting, enzyme-linked immunosorbent assay (ELISA), and chemiluminescence immunoassay (CLIA) were analyzed.
Results
The chimeric A07 antibody recognized the conformational epitopes with high affinity for only non-denatured PR3 and demonstrated the correct cytoplasmic staining pattern in IIF. Line-blotting assays confirmed its specificity and potency. ELISA and CLIA experiments showed well-defined standard curves, with the chimeric antibody displaying consistent reactivity comparable to native PR3-ANCA in serum samples across different antigen conditions.
Conclusions
These findings indicate that the chimeric A07 antibody effectively recognizes both recombinant and native PR3 antigens and can be applied across multiple in vitro PR3-ANCA assays. Furthermore, this antibody may serve as a standard reference for determining serum PR3-ANCA titers or as a substitute for PR3-positive serum in diagnostic applications.
期刊介绍:
The Journal of Immunological Methods is devoted to covering techniques for: (1) Quantitating and detecting antibodies and/or antigens. (2) Purifying immunoglobulins, lymphokines and other molecules of the immune system. (3) Isolating antigens and other substances important in immunological processes. (4) Labelling antigens and antibodies. (5) Localizing antigens and/or antibodies in tissues and cells. (6) Detecting, and fractionating immunocompetent cells. (7) Assaying for cellular immunity. (8) Documenting cell-cell interactions. (9) Initiating immunity and unresponsiveness. (10) Transplanting tissues. (11) Studying items closely related to immunity such as complement, reticuloendothelial system and others. (12) Molecular techniques for studying immune cells and their receptors. (13) Imaging of the immune system. (14) Methods for production or their fragments in eukaryotic and prokaryotic cells.
In addition the journal will publish articles on novel methods for analysing the organization, structure and expression of genes for immunologically important molecules such as immunoglobulins, T cell receptors and accessory molecules involved in antigen recognition, processing and presentation. Submitted full length manuscripts should describe new methods of broad applicability to immunology and not simply the application of an established method to a particular substance - although papers describing such applications may be considered for publication as a short Technical Note. Review articles will also be published by the Journal of Immunological Methods. In general these manuscripts are by solicitation however anyone interested in submitting a review can contact the Reviews Editor and provide an outline of the proposed review.